Related Experiment Video

Updated: Aug 11, 2026

Spatial and Temporal Analysis of Active ERK in the C. elegans Germline
08:40

Spatial and Temporal Analysis of Active ERK in the C. elegans Germline

Published on: November 29, 2016

The ErbB receptor tyrosine family as signal integrators

N E Hynes1, K Horsch, M A Olayioye

  • 1Friedrich Miescher Institute, PO Box 2543, CH-4002 Basel, Switzerland. hynes@fmi.ch

Endocrine-Related Cancer
|September 22, 2001
PubMed

Insights

ErbB2, a key co-receptor in the ErbB receptor tyrosine kinase (RTK) family, lacks direct ligands but enhances signaling. Its central role in malignancies like breast cancer highlights its importance in tumor cell proliferation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • ErbB receptor tyrosine kinases (RTKs) are crucial in development and cancer.
  • ErbB2 functions as a co-receptor, lacking direct ligands but amplifying signaling of other ErbB family members.
  • ErbB2's central role in the ErbB family contributes to various human malignancies, notably breast cancer.

Purpose of the Study:

  • To elucidate the role of ErbB2 as a co-receptor in ErbB signaling pathways.
  • To investigate the involvement of ErbB2 in the development of human cancers.
  • To explore the cross-regulation between ErbB RTKs and cytokine receptors in tumor progression.

Main Methods:

  • Analysis of ErbB receptor tyrosine kinase (RTK) signaling pathways.
  • Investigating the co-receptor function of ErbB2.
  • Examining cross-regulation mechanisms between RTKs and cytokine receptors.

Main Results:

  • ErbB2 lacks direct ligands but significantly enhances ligand binding and signaling for other ErbB receptors.
  • ErbB2's function as a co-receptor is critical for promoting ligand-induced biological responses.
  • ErbB RTKs integrate signals and cross-regulate other receptors, including cytokine receptors, promoting tumor cell proliferation.

Conclusions:

  • ErbB2 plays a pivotal role in ErbB-mediated signaling and is implicated in human cancer development.
  • The cross-regulation between ErbB RTKs and cytokine receptors offers a mechanism for enhanced tumor cell proliferation.
  • Understanding these pathways is crucial for developing targeted cancer therapies.

More Related Videos

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Related Concept Videos

Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: